ambenonium
Ligand Summary
A quaternary ammonium compound that is an inhibitor of cholinesterase activity with actions similar to those of NEOSTIGMINE, but of longer duration. Ambenonium is given by mouth in the treatment of myasthenia gravis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1112)
UNII: L16PUN799N
PubChem: 2131
ChEMBL: CHEMBL1652
DrugCentral: 146
LyCHI: M2W5RT5D46DT
Target Activities
1 Activities
Items per page:
1 – 1 of 1
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
INHIBITOR | ||||||